Golden State Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.1K Buy
163
+5
+3% +$1.85K 0.01% 674
2026
Q1
$46.3K Sell
158
-9
-5% -$2.96K 0.01% 705
2025
Q4
$58.8K Sell
167
-22
-12% -$7.43K 0.01% 649
2025
Q3
$61.2K Sell
189
-4
-2% -$1.24K 0.01% 622
2025
Q2
$75.2K Sell
193
-4
-2% -$1.61K 0.01% 553
2025
Q1
$85.9K Sell
197
-5
-2% -$2.01K 0.01% 483
2024
Q4
$74.7K Buy
+202
New +$84.5K 0.01% 487
2020
Q2
Sell
-261
Closed -$59K 437
2020
Q1
$59K Buy
+261
New +$71.1K 0.03% 333
2019
Q4
Sell
-591
Closed -$142K 291
2019
Q3
$142K Sell
591
-79
-12% -$21.6K 0.05% 254
2019
Q2
$189K Hold
670
0.06% 233
2019
Q1
$192K Buy
+670
New +$194K 0.06% 232

Other funds holding ELV

Golden State Wealth Management's ELV Position: Q2 2026 in Review

Golden State Wealth Management increased its Elevance Health (ELV) stake by 3.2% in Q2 2026, buying an estimated $1.85K and bringing the position to 163 shares worth $63.1K. The position accounts for 0.01% of the portfolio, ranked #674.

Golden State Wealth Management first reported a position in ELV in Q1 2019 and has held it in 11 quarters since. The position peaked at $192K in Q1 2019. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Golden State Wealth Management held 163 shares of Elevance Health worth $63.1K as of Q2 2026.
  • Golden State Wealth Management bought 5 Elevance Health shares in Q2 2026, an estimated $1.85K.
  • Elevance Health made up 0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #674 holding.
  • Golden State Wealth Management first reported a position in Elevance Health in Q1 2019 and has held it in 11 quarters since.
  • Golden State Wealth Management's Elevance Health position peaked at $192K in Q1 2019.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.